Tunde Otulana

Tunde is currently the Chief Medical Officer of Veloxis Pharmaceuticals in North Carolina, the USA since August 2020. Prior to Veloxis, he was Senior Vice President and Chief Medical Officer at Mallinckrodt Pharmaceuticals. His career, which spans about 30 years in the industry, government, and academia, includes leadership roles at Boehringer Ingelheim Pharmaceutical Inc. and the US Food and Drug Administration (“FDA”). Tunde is a physician trained in Pulmonary and Critical Care Medicine.